Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol/Fluticasone vs Seretide in Persistent Asthma
NCT01202097Phase 3Completed
- Sponsor
- Eurofarma
- Start
- Aug 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of salmeterol, fluticasone propionate in asthma, sponsored by Eurofarma. Started Aug 2011; status: completed.
02
Drugs
salmeterolfluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01202097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01202097.